AAV Technology
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
78
NCT06598007
A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 20, 2024
Completion: Jun 30, 2027
Loading map...